Tag: Biomarkers

Prognosis and prospect of metabolomics research of primary open-angle glaucoma

Authors: Xu Jianming,  Zhang Mingzhi DOI: 10.3760/cma.j.cn115989-20220518-00224 Published 2023-12-10 Cite as Chin J Exp Ophthalmol, 2023, 41(12): 1221-1226. Abstract                              [Download PDF] [Read Full Text] Primary open-angle glaucoma (POAG) is an irreversible blinding eye disease that severely threatens and damages the optic nerve […]

Paying attention to the application of proteomics and metabolomics in clinical and translational research of diabetic retinopathy

Authors: Zhang Hui,  Li Xiaorong,  Zhou Lei DOI: 10.3760/cma.j.cn115989-20220831-00406 Published 2022-09-10 Cite asChin J Exp Ophthalmol, 2022, 40(9): 791-795. Abstract                                       [View PDF] [Read Full Text] Diabetic retinopathy (DR) is one of the complications of diabetic mellitus and a major cause of blindness […]

Evaluation of plasma exosomal miR-214-3p as a potential biomarker for diagnosis and prognosis of uveal melanoma

·Clinical Research· Evaluation of plasma exosomal miR-214-3p as a potential diagnostic and prognostic biomarker of uveal melanoma Zhou Wenda, Shao Lei, Dong Li, Shi Xuhan, Zhang Ruiheng, Li Heyan, Wu Haotian, Wei Wenbin Beijing Tongren Eye Center, Beijing Key Laboratory of Intraocular Tumor Diagnosis and Treatment, Beijing Ophtahlmology & Visual Sciences Key Laboratory, Medical Artificial […]

Biomarkers in ocular chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

Authors: Wang Chunmiao,  Zhang Qi DOI: 10.3760/cma.j.cn115989-20190121-00025 Published 2022-05-10 Cite asChin J Exp Ophthalmol, 2022, 40(5): 470-474. Abstract                               [View PDF] [Read Full Text] Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a common treatment for hematological malignant and non-malignant diseases.However, dry eye, ocular chronic graft-versus-host disease […]